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Abstract
Objectives:  Reductions  in  diaphragm  activity  are  associated  with  the  postoperative  develop-
ment of  atelectasis.  Neostigmine  reversal  is  also  associated  with  increased  atelectasis.  We
assessed  the  effects  of  neostigmine,  sugammadex,  and  spontaneous  reversal  on  regional  lung
ventilation  and  airway  ﬂow.
Methods:  Six  Sprague--Dawley  rats  were  paralysed  with  rocuronium  and  mechanically  ventilated
until recovery  of  the  train-of-four  ratio  to  0.5.  We  administered  neostigmine  (0.06  mg/kg),  sug-
ammadex (15  mg/kg),  or  saline  (n  =  2  per  group).  Computed  tomography  scans  were  obtained
during the  breathing  cycle.  Three-dimensional  models  of  lung  lobes  were  generated  using  func-
tional respiratory  imaging  technology,  and  lobar  volumes  were  calculated  during  the  breathing
cycle. The  diaphragmatic  surface  was  segmented  for  the  end-expiratory  and  end-inspiratory
scans. The  total  change  in  volume  was  reported  by  the  lung  volume  change  from  the  end-
expiratory scan  to  the  end-inspiratory  scan.  Chest  wall  movement  was  deﬁned  as  the  lung
volume change  minus  the  volume  change  that  resulted  from  diaphragm  excursion.
Results: The  two  rats  that  received  neostigmine  exhibited  a  smaller  relative  contribution  of
diaphragm movement  to  the  total  change  in  lung  volume  compared  with  the  two  rats  that
received  sugammadex  or  saline  (chest  wall  contribution  (%):  26.69  and  25.55  for  neostigmine;
−2.77 and  15.98  for  sugammadex;  18.82  and  10.30  for  saline).Please  cite  this  article  in  press  as:  Schepens  T,  et  al.  Functional  respiratory  imaging  after  neostigmine-  or  sugammadex-
enhanced  recovery  from  neuromuscular  blockade  in  the  anaesthetised  rat:  a  randomised  controlled  pilot  study.  Rev  Bras
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.11.004
 The experiments were conducted at the Bruker facilities (Kontich, Belgium).
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Conclusion:  This  pilot  study  in  rats  demonstrated  an  increased  relative  contribution  of  chest
wall expansion  after  neostigmine  compared  with  sugammadex  or  saline.  This  smaller  relative
contribution  of  diaphragm  movement  may  be  explained  by  a  neostigmine-induced  decrease  in
phrenic nerve  activity  or  by  remaining  occupied  acetylcholine  receptors  after  neostigmine.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Imagiologia  funcional  respiratória  após  reforc¸o da  recuperac¸ão  do  bloqueio
neuromuscular  com  neostigmina  ou  sugamadex  em  ratos  anestesiados:  estudo  piloto
controlado  e  randomizado
Resumo
Objetivos:  As  reduc¸ões  da  atividade  do  diafragma  estão  associadas  ao  desenvolvimento  de
atelectasia  no  período  pós-operatório.  A  reversão  com  neostigmina  também  está  associada
ao aumento  de  atelectasia.  Avaliamos  os  efeitos  de  neostigmina,  sugamadex  e  da  reversão
espontânea  sobre  a  ventilac¸ão  pulmonar  regional  e  ﬂuxo  aéreo.
Métodos:  Seis  ratos  Sprague-Dawley  foram  paralisados  com  rocurônio  e  mecanicamente  venti-
lados até  a  recuperac¸ão  da  sequência  de  quatro  estímulos  a  0,5.  Administramos  neostigmina
(0,06 mg/kg),  sugamadex  (15  mg/kg)  ou  soluc¸ão  salina  (n  =  2  por  grupo).  As  tomograﬁas  foram
realizadas  durante  o  ciclo  respiratório.  Modelos  tridimensionais  dos  lobos  pulmonares  foram
gerados usando  a  tecnologia  de  imageologia  funcional  respiratória,  e  os  volumes  lobares  foram
calculados  durante  o  ciclo  respiratório.  A  superfície  diafragmática  foi  segmentada  para  as
varreduras expiratória  ﬁnal  e  inspiratória  ﬁnal.  A  alterac¸ão  total  no  volume  foi  relatada  pela
alterac¸ão do  volume  pulmonar  da  varredura  expiratória  ﬁnal  para  a  varredura  inspiratória  ﬁnal.
O movimento  da  parede  torácica  foi  deﬁnido  como  a  variac¸ão  do  volume  pulmonar  menos  a
alterac¸ão no  volume  resultante  da  excursão  do  diafragma.
Resultados:  Os  dois  ratos  que  receberam  neostigmina  apresentaram  uma  contribuic¸ão  relativa
menor do  movimento  do  diafragma  para  a  alterac¸ão  total  do  volume  pulmonar  em  comparac¸ão
com os  dois  ratos  que  receberam  sugamadex  ou  soluc¸ão  salina  (contribuic¸ão  da  parede  torácica
(%): 26,69  e  25,55  para  neostigmina;  -2,77  e  15.98  para  sugamadex;  18,82  e  10,30  para  soluc¸ão
salina).
Conclusão:  Este  estudo  piloto  com  ratos  demonstrou  uma  contribuic¸ão  relativa  aumentada  de
expansão  da  parede  torácica  após  neostigmine  em  comparac¸ão  com  sugamadex  ou  soluc¸ão
salina. Essa  contribuic¸ão  relativa  menor  de  movimento  do  diafragma  pode  ser  explicada  por
uma reduc¸ão  induzida  por  neostigmina  na  atividade  do  nervo  frênico  ou  pelos  receptores  de
acetilcolina  permanecerem  ocupados  após  a  administrac¸ão  de  neostigmina.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este
é um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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introduction
he  use  of  Neuromuscular  Blocking  Agents  (NMBAs)  is  associ-
ted  with  postoperative  pulmonary  complications  at  the  end
f  surgery.1 Respiratory  complications  after  surgery  (e.g.,
esaturation  and  atelectasis)  are  potentially  related  to  the
ack  of  diaphragm  activity,  which  cannot  be  detected  using
eripheral  Acceleromyography  (AMG)  monitoring.2,3
A  previous  trial  by  our  study  group  associated  the
se  of  a  Selective  Relaxant-Binding  Agent  (SRBA)  for  the
eversal  of  neuromuscular  blockade,  sugammadex,  to  anPlease  cite  this  article  in  press  as:  Schepens  T,  et  al.  Functiona
enhanced  recovery  from  neuromuscular  blockade  in  the  anaest
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.11.
ncrease  in  diaphragm  Electromyographic  activity  (EMGdi)
ompared  with  reversal  with  neostigmine.4 More  nicotinic
cetylcholine  receptors  may  be  free  from  rocuronium
n  diaphragmatic  neuromuscular  junctions  after  SRBA
(
w
s
tompared  with  neostigmine,  or  neostigmine  may  exert  a
irect  negative  impact  on  phrenic  nerve  activity.5 These  fac-
ors  may  independently  or  concomitantly  exert  subsequent
ffects  on  central  breathing  control  and  inﬂuence  the  bal-
nce  between  the  accessory  inspiratory  (chest  wall)  muscle
nd  diaphragm  muscle  activity.  We  performed  a  pilot  study
n  rats  using  functional  respiratory  imaging  (FRI,  FLUIDDA,
ontich,  Belgium)  to  assess  regional  lung  ventilation  after
ugammadex,  neostigmine  or  spontaneous  reversal  and  fur-
her  explore  the  balance  between  diaphragm  and  accessory
nspiratory  muscle  activity.  Micro-computed  Tomographyl  respiratory  imaging  after  neostigmine-  or  sugammadex-
hetised  rat:  a  randomised  controlled  pilot  study.  Rev  Bras
004
CT)  scan  images  provided  accurate  reconstructions  of  air-
ay  morphology  in  free-breathing  rats.6 High-resolution  CT
cans  are  limited  to  static  information  of  the  respiratory  sys-
em  without  additional  post-imaging  processing.  FRI  enables
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Figure  1  Assessment  of  neuromuscular  transmission  using
accelerometry  with  the  TOF  Watch  SX,  subcutaneous  needle
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Functional  respiratory  imaging  after  neostigmine  or  sugamm
studies  of  regional  ﬂow  and  allows  structural  simulations.
Different  airway  sections  are  associated  with  corresponding
lung  tissue  to  render  a  full  anatomical  picture.  A  comparison
of  morphological  scans  at  different  breathing  levels  (e.g.,
end-inspiratory  and  end-expiratory)  allows  the  modelling
of  regional  airway  and  alveolar  recruitment.
Methods
This  study  was  a  randomised,  controlled,  parallel-group
double-blinded  trial  in  rats.  We  compared  spontaneous  (no
drug)  reversal  with  neostigmine-  or  sugammadex-enhanced
reversal  of  a  rocuronium-induced  neuromuscular  blockade.
Animal  protocols  strictly  adhered  to  the  institutional  guide-
lines  for  animal  care  and  use  for  research  purposes.  Approval
of  the  Committee  for  Medical  Ethics  and  the  Use  of  Exper-
imental  Animals  at  the  University  of  Antwerp,  Belgium
was  obtained  (Ref.  2014-63,  Chairperson  Prof.  Dr.  P.  De
Deyn)  on  November  17,  2014.  The  study  was  registered  as
NCT02284412.  Every  effort  was  made  to  minimise  the  num-
ber  of  rats  used.  The  experiments  were  conducted  at  the
Bruker  facilities  (Kontich,  Belgium),  and  qualiﬁed  personnel
performed  all  experimental  animal  procedures.
Experimental  animal  preparation
Six  adult  male  Sprague--Dawley  rats  (LA  number:  1100155)
weighing  377--451  g  were  fed  a  standard  pellet  diet  and
water  ad  libitum.  Room  temperature  and  humidity  were
monitored  daily  and  kept  constant.  Twelve-hour  light  and
dark  cycles  were  provided.  The  6  animals  were  randomised
to  one  of  the  following  three  groups  in  a  1:1:1  ratio  accord-
ing  to  a  computer-generated  randomisation  list:  0.06  mg/kg
neostigmine,  15  mg/kg  sugammadex7 or  saline.  All  drugs
were  obtained  from  clinical  supplies.  Anaesthesia  was
induced  in  an  induction  chamber  using  5%  isoﬂurane,  and
anaesthesia  was  maintained  with  1.5--2.5%  isoﬂurane  in  air-
oxygen.  A  tail  vein  and  the  trachea  were  cannulated  after
anaesthesia  induction.  The  rats  were  placed  in  a  supine  posi-
tion  with  the  head  in  a  neutral  position  and  connected  to  a
breathing  circuit  (Harvard  model  683  Small  Animal  Ventila-
tor,  Holliston,  MA,  USA).  Body  temperature  was  measured
using  a  rectal  probe  and  maintained  at  >36 ◦C  using  a  ther-
mostatically  controlled  heating  plate.  Heart  rate,  breathing
frequency  and  paw  skin  colour  were  maintained  within  nor-
mal  ranges.
The  right  leg  was  shaved,  and  the  femoral  nerve  was
stimulated  supramaximally  using  subcutaneous  needle  elec-
trodes  (B.  Braun  Melsungen  AG,  Melsungen,  Germany)  for
assessments  of  neuromuscular  transmission.  The  evoked
response  of  the  femoral  muscle  was  measured  using
accelerometry  with  the  TOF-Watch  SX  (MIPM  Mammendorfer
Institut  für  Physik  und  Medizin  GmbH,  Munich,  Germany),  as
described  previously.7 The  transducer  was  ﬁxed  to  the  skin
ventromedially  at  the  proximal  end  of  the  thigh  (Fig.  1).  The
supramaximal  stimulation  current  was  determined,  and  the
femoral  nerve  was  continuously  stimulated  at  1  Hz  (8--10  mA)Please  cite  this  article  in  press  as:  Schepens  T,  et  al.  Functiona
enhanced  recovery  from  neuromuscular  blockade  in  the  anaest
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.11.0
until  the  twitch  height  reached  a  stable  plateau.  The  stimu-
lation  pattern  was  changed  thereafter  to  train-of-four  (TOF)
stimulation  (2  Hz)  applied  for  a  minimum  of  3  min  to  cali-
brate  the  TOF-Watch  SX  monitor  (calibration  mode  1).  TOF
s
s
n
blectrodes  for  femoral  nerve  stimulation  and  transducer  place-
ent on  the  rat  thigh  for  muscle  response  measurements.
timulation  was  continued  for  at  least  2  min  before  injection
f  the  NMBA.  Rocuronium  (3.5  mg/kg,  2  times  the  effective
ose  (ED)  90)  was  injected,  and  the  lungs  were  ventilated
sing  a  2.5  mL  tidal  volume,  90  breaths  per  minute  ven-
ilation  scheme.  TOF  stimulation  with  a  15  s interval  was
ontinued  throughout  the  remainder  of  the  procedure.
We  administered  0.06  mg/kg  neostigmine,  15  mg/kg  sug-
mmadex  or  saline  at  a  TOF  =  0.5.  Neostigmine  was  dosed
s  0.06  mg/kg,  and  glycopyrrolate  was  used  at  0.012  mg/kg
commercially  available  5:1  co-formulation).  The  syringes
hat  contained  sugammadex  or  neostigmine/glycopyrrolate
ontained  approximately  1  mL  of  ﬂuid.  Therefore,  the  third
roup  received  1  mL  of  saline.  All  prepared  syringes  were
overed  with  tape  to  mask  the  potential  colour  and  ﬂuid
olume  differences  as  an  additional  precaution  for  blinding.
ll  drugs  were  administered  intravenously  over  5--10  s  via
he  tail  vein  and  ﬂushed  with  0.5  mL  of  saline.  TOF  monitor-
ng  was  removed  for  practical  reasons  at  a  TOF  ratio  ≥0.9,
nd  the  animals  were  placed  in  the  CT  scanner  in  a  prone
osition.  Animals  were  allowed  to  breathe  spontaneously
hrough  a  custom-designed  breathing  system.  Weaning  off
rtiﬁcial  ventilation  was  performed  via  a  gradual  lowering  of
espiratory  frequency  until  full  spontaneous  breathing  was
bserved.  The  animals  remained  under  anaesthesia  (1.5%
soﬂurane),  and  CT  scanning  was  initiated  as  soon  as  possi-
le.  The  front  paws  and  tail  were  loosely  ﬁxed  aside  when
he  rat  was  in  the  CT  tube  to  clear  these  appendages  from
he  ﬁeld  of  view  (Fig.  2).  We  targeted  a  light  anaesthe-l  respiratory  imaging  after  neostigmine-  or  sugammadex-
hetised  rat:  a  randomised  controlled  pilot  study.  Rev  Bras
04
ia  depth  (righting  reﬂex  lost,  marked  response  to  painful
timuli)  during  the  remaining  procedure,  including  the  scan-
ing  period,  instead  of  a  surgical  depth  of  anaesthesia
efore  intubation  and  placement  of  the  cannulae.  We  used
ARTICLE IN+ModelBJANE-747; No. of Pages 7
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Figure  2  Top:  Position  of  the  rat  in  the  CT  tube.  Bottom:
The physiological  monitoring  system  included  video  monitor-
ing of  the  rat  with  real-time  breathing  detection.  The  software
analyses  the  video  stream  from  the  point  where  breathing
movement  is  visible.  These  movements  are  converted  into
a movement  waveform  to  provide  breathing  time  marks  for
time-resolved  micro-CT  reconstruction.  Top  and  bottom:  The
anaesthetic  delivery  facemask  on  the  animal  is  connected  to  a
ﬂow sensor  for  direct  breathing  detection.  Multiple  projection
i
i
t
t
d
r
a
I
W
m
p
a
c
p
i
r
o
p
i
o
o
a
T
f
3
p
T
m
i
c
a
b
t
a
T
C
r
i
v
i
m
t
t
e
n
r
w
p
R
T
T
r
r
r
s
r
r
v
i
n
l
o
c
t
r
m
c
c
t
T
l
images  obtained  at  each  angular  position  are  sorted  post-scan
nto breathing  time  bins  using  recorded  physiological  monitoring
ime  marks.
he  respiratory  frequency  as  parameters  for  anaesthesia
epth  maintenance  during  the  CT  scanning  period  when  the
ats  were  inaccessible.  All  records  were  kept  and  stored.  All
nimals  were  euthanised  at  the  end  of  the  procedure.
maging
e  used  the  SkyScan  1278  in  vivo  micro-CT  scanner  (Bruker
icroCT,  Kontich,  Belgium).  This  system  has  integrated
hysiological  monitoring,  including  breathing  movement,
nd  four-dimensional  (4D)  time-resolved  microtomography
apabilities.  Dynamic  scanning  techniques,  as  used  in  the
resent  4D  free-breathing  CT  scan  protocol,  exhibit  the
ntrinsic  problem  of  motion  artefacts.  We  used  the  respi-
atory  gating  technique  to  reduce  these  artefacts.  MotionPlease  cite  this  article  in  press  as:  Schepens  T,  et  al.  Functiona
enhanced  recovery  from  neuromuscular  blockade  in  the  anaest
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.11.
f  the  animal’s  thorax  was  registered,  and  their  breathing
atterns  were  monitored  to  apply  this  gating.  The  gat-
ng  thresholds  were  set  on  these  recordings.  Scans  were
btained  using  a  source  voltage  of  70  kV  and  a  source  current
V
s
p
f PRESS
T.  Schepens  et  al.
f  140  A.  The  resolution  was  set  to  100  m.  The  scanner  had
n  8  cm  wide  ﬁeld  of  view,  which  spanned  the  entire  thorax.
he  retrospectively  synchronised  ‘‘listmode’’  scan  was  per-
ormed  with  an  exposure  time  of  40  ms,  a  scan  rotation  of
60◦ and  step  of  0.75◦.  Twenty-ﬁve  images  were  acquired
er  step  for  subsequent  sorting  into  breathing  cycle  phases.
he  time  of  all  video-recorded  breathing  inhalation  move-
ent  maxima  and  the  time  of  acquisition  of  all  projection
mages  were  recorded  during  the  scan  in  text  ﬁles  with  a  pre-
ision  of  ±1  ms  to  facilitate  listmode  sorting.  End-expiratory
nd  end-inspiratory  gated  and  binned  images  around  tidal
reathing  were  further  processed.  The  respiratory  wave-
rain  was  displayed  in  real-time,  and  data  were  exported
t  the  end  of  the  scanning  process  for  further  reference.
he  entire  scanning  procedure  took  between  18  and  24  min.
T  images  were  post-processed  to  assess  segmentation  and
egional  ﬂow  patterns  and  visualise  and  quantify  the  follow-
ng  parameters  of  the  micro-CT  images:  (1)  lung  and  lobe
olumes  at  inspiration  and  expiration;  (2)  airway  volumes  at
nspiration  and  expiration;  (3)  diaphragm  shape  and  defor-
ation  with  resulting  lung  volume  change  from  inspiration
o  expiration;  and  (4)  skeletal  movement  from  inspiration
o  expiration.  These  parameters  were  used  to  assess  differ-
nces  between  treatment  groups.
The  present  study  compared  the  effect  of  sugammadex,
eostigmine/glycopyrrolate  and  spontaneous  reversal  on
egional  lung  ventilation.  All  comparisons  were  performed
ith  an  exploratory  intent,  and  no  statistical  analyses  were
erformed.  Data  are  expressed  as  absolute  values  (%).
esults
he  time  from  rocuronium  administration  to  recovery  of  the
OF  ratio  to  0.5  was  14  min  and  14  min  in  the  rats  that
eceived  neostigmine,  15  min  and  21  min  in  the  rats  that
eceived  sugammadex,  and  14  min  and  16  min  in  rats  that
eceived  saline.  The  time  from  the  start  of  neostigmine  or
ugammadex  or  saline  administration  to  recovery  of  the  TOF
atio  to  0.9  was  120  and  90  s,  45  and  90  s,  and  120  and  360  s,
espectively.
Lung  lobes  were  segmented  and  divided  for  FRI  based  on
isible  lobar  ﬁssures  on  the  CT  scan.  There  are  ﬁve  lung  lobes
n  the  rat:  one  Left  Lobe  (LL)  and  four  lobes  on  the  right  (cra-
ial  (RCrL),  middle  (RML),  caudal  (RCL)  and  accessory  (RAL)
obes).  The  accessory  lobe  contacts  the  diaphragm  and  apex
f  the  heart  and  it  is  notched  to  accommodate  the  caudal
aval  vein.8 Fig.  3  presents  an  example  of  the  3D  reconstruc-
ion  of  the  lung  lobes  for  one  rat.  The  ﬁssure  dividing  the
ight  cranial  lobe  and  the  right  middle  lobe  was  not  visible  on
ost  of  the  scans,  and  the  right  cranial  lobe  often  appeared
ollapsed.  Therefore,  these  lobes  were  not  separated  and
onsidered  a  single  lobe  for  all  subsequent  analyses.
Lobar  volumes  were  reconstructed  for  all  rats,  and
otal  lung  volumes  were  calculated  using  these  models.
he  relative  lobar  growth  from  the  end-expiratory  scan
evel  (hereafter  referred  to  as  FRC)  to  the  end-
nspiratory  scan  level  (hereafter  referred  to  as  TLC),l  respiratory  imaging  after  neostigmine-  or  sugammadex-
hetised  rat:  a  randomised  controlled  pilot  study.  Rev  Bras
004
TLClobe −  VFRClobe/VTLClungs −  VFRClungs,  was  considered  a  mea-
ure  for  the  internal  distribution  of  inhaled  air.  Table  1
resents  lobar  and  total  lung  volume  values  at  FRC  and  TLC
or  all  rats.  Internal  airﬂow  distribution  was  calculated  for
Please  cite  this  article  in  press  as:  Schepens  T,  et  al.  Functional  respiratory  imaging  after  neostigmine-  or  sugammadex-
enhanced  recovery  from  neuromuscular  blockade  in  the  anaesthetised  rat:  a  randomised  controlled  pilot  study.  Rev  Bras
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.11.004
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Table  1  Lobar  and  total  lung  volumes  (in  mL)  at  the  end-expiratory  scan  (FRC)  and  end-inspiratory  scan  (TLC).
Neostigmine  Sugammadex  Saline
FRC  TLC  FRC  TLC  FRC  TLC  FRC  TLC  FRC  TLC  FRC  TLC
RCrL  +  RML  0.60  1.14  0.81  1.22  0.66  0.95  1.12  1.80  1.42  1.74  0.43  0.81
RCL 1.69  2.48  1.72  3.09  2.33  2.91  1.83  2.56  2.42  3.58  1.55  2.65
RAL 0.73  1.09  0.73  1.39  1.01  1.49  0.40  0.56  0.70  1.03  0.41  0.83
LL 1.81  2.58  2.26  3.73  1.70  2.24  1.84  2.60  1.82  2.51  0.52  1.07
Total 4.84  7.29  5.52  9.43  5.70  7.60  5.19  7.52  6.36  8.86  2.91  5.36
RCrL, right cranial lobe; RML, right middle lobe; RCL, right caudal lobe; RAL, right accessory lobe; LL, left lobe.
Table  2  Internal  airﬂow  distribution  (%)  from  the  end-expiratory  scan  (FRC)  to  the  end-inspiratory  scan  (TLC).
Neostigmine  Sugammadex  Saline
RCrL  +  RML  21.77  10.31  15.29  29.14  13.07  15.49
RCL 32.24  35.27  30.72  31.31  46.42  45.06
RAL 14.69  16.74  25.55  6.84  13.28  16.82
LL 31.30  37.68  28.44  32.70  27.22  22.63
RCrL, right cranial lobe; RML, right middle lobe; RCL, right caudal lobe; RAL, right accessory lobe; LL, left lobe.
each  rat  using  these  values,  and  the  results  are  presented
in  Table  2.
Three-dimensional  models  of  the  diaphragmatic  surface
were  generated  for  FRC  and  TLC  after  the  identiﬁcation  of
the  FRC  and  TLC  scans  based  on  the  total  lung  volumes,
as  exempliﬁed  in  Fig.  4  (same  rat  as  Fig.  3).  Diaphragm
movement  was  assessed  by  measuring  the  volume  contained
between  the  two  surfaces.  The  total  change  in  volume  is
indicated  by  the  lung  volume  change  from  FRC  to  TLC.
Figure  3  Three-dimensional  reconstruction  of  the  lung  lobes
at the  end-inspiratory  scan  for  one  of  the  study  rats.  Right  cra-
nial lobe  (RCrL)  --  red;  right  middle  lobe  (RML)  --  yellow;  right
caudal  lobe  (RCL)  --  orange;  right  accessory  lobe  (RAL)  --  green;
left lobe  (LL)  --  blue.
Therefore,  the  chest  wall  movement  was  deﬁned  as  the  total
lung  volume  change  minus  the  lung  volume  change  resulting
from  diaphragmatic  movement.
Table  3  summarises  the  calculations  that  were  performed
to  obtain  the  relative  contributions  of  the  chest  wall  expan-
sion  and  diaphragm  movement  to  the  total  change  of  lung
volume.  The  relative  contribution  of  chest  wall  expansion
was  increased  in  neostigmine-treated  rats  compared  with
sugammadex-  or  saline-treated  rats  (chest  wall  contribution
(%):  26.69  and  25.55  for  neostigmine;  −2.77  and  15.98  for
sugammadex;  18.82  and  10.30  for  saline).
Discussion
This  pilot  study  compared  the  effects  of  sugammadex,
neostigmine/glycopyrrolate  and  spontaneous  reversal  on
regional  lung  ventilation  in  rats  paralysed  with  rocuronium
and  reversed  (or  not)  at  a  TOF  ratio  of  0.5.  CT  scans  were
obtained  after  recovery  of  the  TOF  ratio  >0.9  during  the
spontaneous  breathing  cycle,  and  3D  models  of  the  lung
lobes  were  generated  using  FRI  technology  to  calculate
lobar  volumes.  The  relative  contributions  of  the  chest  wall
Figure  4  3D  reconstruction  of  the  diaphragm  at  the  end-
inspiratory  scan  (TLC)  --  yellow  and  the  end-expiratory  scan
(FRC) --  red.
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Table  3  Total  lung,  diaphragm  and  chest  wall  volume  changes  from  the  end-expiratory  scan  (FRC)  to  the  end-inspiratory  scan
(TLC) and  the  relative  contribution  of  the  chest  wall  expansion  and  diaphragm  movement  to  the  total  volume  change.
Neostigmine  Sugammadex  Saline
Total  lung  volume  change  (mL)  2.46  3.91  1.91  2.34  2.51  2.45
Diaphragm volume  change  (mL)  1.80  2.91  1.96  1.97  2.04  2.20
Chest wall  volume  change  (mL)  0.66  1.00  −0.05  0.37  0.47  0.25
Diaphragm contribution  (%)  73.31  74.45  102.77  84.02  81.18  89.70
Chest wall  contribution  (%)  26.69  25.55  −2.77  15.98  18.82  10.30
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Rxpansion  and  diaphragm  movement  to  the  total  change
f  lung  volume  were  obtained.  The  two  rats  that  received
eostigmine  as  a  reversal  agent  displayed  a  smaller  rela-
ive  contribution  of  diaphragm  movement  to  total  change  in
ung  volume  compared  with  rats  that  received  sugammadex
r  saline.  Consequently,  the  relative  contribution  of  chest
all  expansion  was  increased  in  neostigmine  rats  compared
ith  rats  that  received  sugammadex  or  saline.
The  exact  effect  of  neuromuscular  blockade  and  rever-
al  agents  on  the  diaphragm  in  a  perioperative  setting
s  not  well  studied.  Mechanical  ventilation  and  rocuro-
ium  play  independent  roles  in  diaphragmatic  dysfunction.9
echanical  ventilation  exerts  relatively  short-term  effects
n  the  rat  diaphragm,  including  a  reduction  in  blood  ﬂow,
hich  impairs  oxygen  uptake.10 However,  good  diaphrag-
atic  function  is  essential  in  patients  at  the  end  of  surgery
hen  spontaneous  breathing  is  resumed.  The  diaphragm  is
he  most  important  inspiratory  muscle,  and  reductions  in
iaphragm  activity  are  associated  with  the  development  of
telectasis  postoperatively.2
A  previous  study  compared  the  effects  of  neostig-
ine/glycopyrrolate  and  sugammadex  on  EMGdi.4 EMGdi,
idal  volume  and  PaO2 following  tracheal  extubation  at
 TOF  ratio  >0.9  decreased  after  neostigmine  compared
ith  sugammadex,  which  reﬂects  a  reduced  diaphragm-
riven  inspiration  after  neostigmine.  Eikermann  et  al.11
emonstrated  that  neostigmine  alone  (without  prior  treat-
ent  with  a  NMBA)  decreased  diaphragmatic  EMG  activity.
eostigmine  reversal  was  recently  associated  with  increased
telectasis  and  longer  postoperative  hospital  stays.  The
nwarranted  use  of  neostigmine  (neostigmine  administra-
ion  without  appropriate  guidance  from  neuromuscular
ransmission  monitoring)  is  associated  with  an  increased
ncidence  of  pulmonary  oedema  and  reintubation.12 These
tudy  results  are  consistent  with  the  ﬁndings  from  a  previous
pidemiological  study  that  revealed  an  absence  of  bene-
cial  effects  of  neostigmine  on  postoperative  oxygenation
nd  reintubation.1,13
Our  pilot  study  in  rats  demonstrated  that  unwarranted
eostigmine  use  was  not  an  issue  because  reversal  was
ot  administered  earlier  than  a  TOF  ratio  of  0.5,  and  FRI
ccurred  after  recovery  of  the  TOF  ratio  >0.9.  However,
he  two  rats  that  received  neostigmine  as  a  reversal  agent
xhibited  a  smaller  relative  contribution  of  diaphragm
ovement  to  the  total  change  in  lung  volume  comparedPlease  cite  this  article  in  press  as:  Schepens  T,  et  al.  Functiona
enhanced  recovery  from  neuromuscular  blockade  in  the  anaest
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.11.
ith  rats  that  received  sugammadex  or  saline.  This  result
ay  be  explained  by  an  effect  on  neuromuscular  trans-
ission  because  the  remaining  occupied  acetylcholine
eceptors  after  neostigmine  administration  may  decreasehe  efﬁciency  of  neuromuscular  coupling  at  the  diaphragm
n  contrast  to  sugammadex.  Alternatively,  we  hypothesise
hat  the  increased  relative  contribution  of  rat  chest  wall
xpansion  after  neostigmine  compared  with  sugammadex
r  saline  may  also  be  explained  by  a  neostigmine-induced
ecrease  in  phrenic  nerve  activity.  Neostigmine  reduced
fferent  phrenic  nerve  activity  before  neuromuscular
lockade  at  the  gastrocnemic  muscle  in  cats.5
ummary
ats  in  this  pilot  study  exhibited  a  smaller  relative  contri-
ution  of  diaphragm  movement  to  the  total  change  in  lung
olume  after  a neostigmine-enhanced  recovery  to  a  TOF
atio  of  at  least  0.9  compared  with  sugammadex  or  saline,
hich  consequently  recruited  secondary  respiratory  muscles
s  primary  breathing  muscle.  Limitations  of  our  pilot  study
nclude  the  use  of  an  animal  model,  the  small  number  of
ubjects,  and  the  possible  imprecision  associated  with  the
esults.  The  relevance  to  human  biology  requires  further
nvestigation.
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